表紙
市場調查報告書

冠狀動脈支架的全球市場:成長,趨勢,預測(2019∼2024年)

Coronary Stent Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 802335
出版日期 內容資訊 英文 118 Pages
商品交期: 2-3個工作天內
價格
冠狀動脈支架的全球市場:成長,趨勢,預測(2019∼2024年) Coronary Stent Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年02月01日內容資訊: 英文 118 Pages
簡介

冠狀動脈疾病的罹患率,在包含印度的低∼中所得國家過去30年大幅增加。冠狀動脈支架市場,由於冠狀動脈疾病的罹患率上升,高齡化,支架技術的進步等促進成長。

本報告提供全球冠狀動脈支架市場相關調查,市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業簡介的相關資訊。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 市場趨勢

  • 市場概要
  • 推動市場的要素
    • 冠狀動脈疾病的罹患率上升
    • 高齡化
    • 冠狀動脈支架的技術進步
  • 阻礙市場的要素
    • 高產品回收度
    • 嚴格的認證流程
  • 波特五力分析

第5章 市場區隔

  • 各產品
    • 藥劑溶出性血管支架
    • 傳統金屬支架
    • 人體可吸收支架
  • 各生醫材料
    • 金屬
    • 聚合物
    • 天然
  • 各終端用戶
    • 醫院
    • 門診外科中心
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭環境

  • 企業簡介
    • Abbott Laboratories
    • B. Braun Medical Inc.
    • Biosensors International Group, Ltd.
    • BIOTRONIK SE & Co. KG
    • Boston Scientific Corporation
    • IRIDEX Corporation
    • Medtronic PLC
    • Terumo Corporation
    • Translumina GmbH

第7章 市場機會與未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 64418

Market Overview

The major factors found propelling the growth of the market include the increasing prevalence of coronary artery diseases (CADs), rising the geriatric population, and the technological advancements in coronary stents.

The prevalence of coronary artery disease (CAD) has increased in the past three decades in the low- and middle-income countries, including India. Coronary artery disease is responsible for 20% of the total deaths in India. Thus the burden of CAD has increased and has boosted the usage of coronary stents, thus helping in driving the market growth. In addition, the increasing geriatric population has also increased the demand for coronary stents that is expected to rise over the forecast period.

There has also been a high demand for minimally invasive surgical procedures that is likely to significantly drive the coronary stent market. Thus, there has been a reduction in post-operative trauma and complications with the use of a minimally invasive surgical procedure, which is the major growth driver. Reduced hospital stays and lesser healing time are the other advantages associated with the use of advanced and miniaturized coronary stents.

Scope of the Report

As per the scope of the report, coronary stents are small elastic tubes used for the treatment of narrowed and blocked coronary arteries in patients with coronary artery disease (CAD). These reduce the symptoms of chest pain (angina) and aid in the treatment of a heart attack. These types of stents are also called as heart stents or cardiac stents. They comprise metal mesh and are implanted in constricted coronary arteries during a technique known as percutaneous coronary intervention (PCI) or angioplasty.

Key Market Trends

Drug-eluting Stent is the Largest Segment by Product Type that is Expected to Grow during the Forecast Period

The drug-eluting stent segment has accounted for the largest revenue, as it can be used for the treatment of a large number of disorders, such as diabetes, renal disease, percutaneous coronary intervention, and ST-segment elevation myocardial infarction (STEMI). There are also various technological advances seen in the drug-eluting stent segment that may witness tremendous growth.

North America Experienced the Largest Growth and is Expected to Follow the Same Trend Over the Forecast Period

North America holds the largest market share for coronary stents, due to the dominance of the top companies present in the global market. There is also an increase in the ageing population, an increase in the prevalence of heart diseases, and technological advancements found in the region. In addition, other factors, such as good reimbursement scenario, have been driving the North American coronary stent market.

Competitive Landscape

The major companies have adopted strategies like mergers and acquisitions and strategic alliances to gain a competitive advantage in the market. Additionally, companies are also more focused on the development of technologically advanced products, which deliver greater accuracy and efficiency.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Coronary Artery Diseases (CADs)
    • 4.2.2 Rising of the Geriatric Population
    • 4.2.3 Technological Advancements in Coronary Stents
  • 4.3 Market Restraints
    • 4.3.1 High Product Recalls
    • 4.3.2 Stringent Approval Process for Stents
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Drug Eluting Stent
    • 5.1.2 Bare Metal Coronary Stent
    • 5.1.3 Bioabsorbable Stent
  • 5.2 By Biomaterial
    • 5.2.1 Metallic Biomaterial
    • 5.2.2 Polymeric Biomaterial
    • 5.2.3 Natural Biomaterial
  • 5.3 By End User
    • 5.3.1 Hospital
    • 5.3.2 Ambulatory Surgical Centre
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 B. Braun Medical Inc.
    • 6.1.3 Biosensors International Group, Ltd.
    • 6.1.4 BIOTRONIK SE & Co. KG
    • 6.1.5 Boston Scientific Corporation
    • 6.1.6 Cook Medical Technologies
    • 6.1.7 Medtronic PLC
    • 6.1.8 Terumo Corporation
    • 6.1.9 Translumina GmbH

7 MARKET OPPORTUNITIES AND FUTURE TRENDS